Frontage Holdings Corporation is a contract research organization specializing in laboratory and research services for the pharmaceutical, biotechnology, and agrochemical sectors. Its core offerings span the entire drug development lifecycle, including drug discovery, preclinical and clinical development, and laboratory testing services. Notable capabilities include medicinal chemistry, pharmacology, absorption, distribution, metabolism, and excretion (ADME) studies, as well as drug metabolism and pharmacokinetics (DMPK), safety and toxicology assessments, and early phase clinical support. The company also provides analytical, bioanalytical, genomics, and central laboratory services, supporting clients from lead optimization to clinical trial material manufacturing and regulatory submissions. Headquartered in Exton, Pennsylvania, Frontage Holdings operates across North America, China, and other global markets. As a subsidiary of Hongkong Tigermed Co., Limited, it serves a broad roster of customers in the life sciences, chemical, and animal health industries, enabling efficient, compliant, and innovative drug development worldwide.